Assessment of Knowledge, Attitude, and Practice of Physicians toward Pharmacovigilance in Public and Private Hospitals in Jordan

Knowledge, attitude, and practice toward pharmacovigilance (PV) among healthcare providers is strongly associated with the reporting of adverse drug reactions (ADRs). This study was conducted to evaluate knowledge, attitude, and practice toward pharmacovigilance and to identify barriers for ADR reporting among physicians working in public and private hospitals in Jordan. This study was conducted using an online questionnaire in Arabic, designed by members of the Health Hazard Evaluation Committee of the Jordan Food and Drug Administration (JFDA) between August 2016 to December 2017. The questionnaire was completed using Google Forms online. A total of 341 physicians completed the questionnaire online. The rate of reporting of ADRs is low among physicians as only 4.7% have reported an ADR. The majority of physicians had never heard the term PV before. Respondents also lacked awareness of the existence of a PV center in Jordan and were unaware that ADR monitoring is carried out by the JFDA. Although most of the physicians had never seen the ADR form, many had positive attitudes toward reporting ADRs. According to participant responses, the main barriers to reporting are: 1) not knowing how to report; 2) not knowing the importance of reporting; 3) the unavailability of the ADR form; and, 4) general time pressure in the work environment. Although there is a low rate of ADR reporting among physicians, doctors have a positive attitude toward PV and are willing to implement ADR reporting in their practices. More education and training sessions are needed to raise physician awareness and knowledge of PV, and to enhance ADR reporting.